Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: life extension – Page 478

In my life as a human, I see clues that evolution on Earth and elsewhere in the cosmos at large is not being pushed from behind in entropic randomness but being pulled forward by complexification, natural selection and other evolutionary forces orchestrated by a strange unseen teleological attractor, in McKenna’s words “the Transcendental Object” at the end of time. One may see significant overlapping ideas between the transhumanist Technological Singularity and the Teilhardian Omega Point. The coming Technological Singularity could unravel one of the deepest mysteries of fractal hyperreality: consciousness alternating from pluralities to singularities and from singularities back to pluralities. We are already immortal, but the forthcoming Syntellect Emergence when your mind is digitized, will preserve some of your organic memories if you so desire, and most importantly, will ensure the continuity of your subjectivity into the higher realms of existence. #LifeboatFoundation

By Alex Vikoulov.

Picture

“If the doors of perception were cleansed then everything would appear to man as it is, Infinite. For man has closed himself up, till he sees all things through narrow chinks of his cavern” –William Blake.

Continue reading “The Omega Point Cosmo-Teleology: Our Forgotten Future (The Origins of Us, Part III)” | >

LEAF’s August 2018 roundup is out!

We hope August has treated you well—it certainly did so for life extension, as this has been another month full of great news for the field. Don’t be upset with the departure of summer and the arrival of autumn, because little by little, we’re getting close to pushing away the autumn of years.

More investments against aging

The fight against aging is being taken more and more seriously by a growing number of investors, who realize the world-changing potential of effective rejuvenative treatments as well as the great opportunity for profit. Juvenescence Limited, which recently closed a 10-million deal with Ichor Therapeutics‘ Antoxerene, has now announced the purchase of 14.4 million shares of BioTime’s AgeX Therapeutics—a company focused on extending healthy human lifespan—for a total of over $43 million. AgeX’s work focuses on telomerase upregulation and cell therapies, and Juvenescence has invested in AgeX before. The news has been reported and commented on on Fight Aging! as well.

Continue reading “Rejuvenation Roundup August 2018” | >

An extraordinary new anti-ageing technique could see humans live to 150 years old and allow them to regrow their organs by 2020.

Harvard Professor David Sinclair and researchers from the University of New South Wales developed the new process, which involves reprogramming cells.

Dr Sinclair said the technique could allow people to regenerate organs, and even allow paralysis sufferers to move again, with human trials due within two years.

Read more

The ability to reverse ageing is something many people would hope to see in their lifetime. This is still a long way from reality, but in our latest experiment, we have reversed the ageing of human cells, which could provide the basis for future anti-degeneration drugs.

Ageing can be viewed as the progressive decline in bodily function and is linked with most of the common chronic diseases that humans suffer from, such as cancer, diabetes and dementia. There are many reasons why our cells and tissues stop functioning, but a new focus in the biology of ageing is the accumulation of “senescent” cells in the tissues and organs.

Senescent cells are older deteriorated cells that do not function as they should, but also compromise the function of cells around them. Removal of these old dysfunctional cells has been shown to improve many features of ageing in animals such as the delayed onset of cataracts.

Read more

Citi has produced another of its Disruptive Innovations publications, which takes a look at what it considers to be the top ten disruptive technologies. It is a sign of the changing times that anti-aging medicines are number 2 in its list.

1. All-Solid-State Batteries 2. Anti-Aging Medicines 3. Autonomous Vehicle Networks 4. Big Data & Healthcare 5. Dynamic Spectrum Access 6. eSports 7. 5G Technology 8. Floating Offshore Wind Farms 9. Real Estate Market Disruptors 10. Smart Voice-Activated Assistants.

What was considered fringe science a decade ago is now rapidly becoming a mainstream industry. Our understanding of aging has advanced quickly in the last 10 years, and the tools and innovations seem to come more quickly with each passing year. A variety of therapies that target different aging processes are in development, and some are at fairly advanced stages; if you are interested in their progress, check out the Rejuvenation Roadmap.

Read more

My new article just out: The transhuman future of Quantum Archaeology & living forever is complicated, but it could still be funded by Christians if they rallied around resurrecting Jesus with 3D Bioprinting and Super Computers:

Read more

Researchers have demonstrated that telomerase gene therapy does not increase the risk of cancer, even in strains of mice that are particularly susceptible to cancer [1].

A tale of telomeres

Short telomeres trigger cellular senescence and are thought to be one of the primary hallmarks of aging, which has led to various researchers seeking ways to restore the telomeres in order to prevent cells from dying and to encourage division and tissue regeneration. We won’t go over the basics of telomeres and how they influence aging here, but if you would like to learn more, check out our telomeres article, which explains it all.

Read more

Our ultimate mission is to make 100 years old the new 60.”

A new exploration of stem cells from placentas could drastically advance regenerative medicine. Peter Diamandis, X-Prize and Singularity University founder, recently teamed up with Robert Hariri, the founder of Celgene Cellular Therapeutics, to study these specific stem cells in the hopes of discovering new regenerative therapies.

The initiative, called Celularity, is built around the idea that stem cells found in the human placenta (which transports nutrients to fetuses as they grow) are ideal for regenerating tissue and organs. According to Celularity, the cells can be taken from any placenta, which typically just gets discarded, and placed into any human without the risk of rejection.

Read more